The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis-Reference-Cited by-同舟云学术

The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis

Published:2001-06 Issue:1 Volume:2 Page:47-56
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Morrison Vicki A.,Picozzi Vincent,Scott Shane,Pohlman Brad,Dickman Elliot,Lee Martin,Lawless Grant,Kerr Robert,Caggiano Vincent,Delgado David,Fridman Moshe,Ford Jon,Carter William B.

Publisher

Elsevier BV

Subject

Cancer Research

Reference60 articles.

1. SEER Cancer Statistics' Review, 1973-1996,1999

2. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking;Wingo;J Natl Cancer Inst,1999

3. Prognosis and management strategies of lymphatic neoplasias in the elderly. I. Aggressive non-Hodgkin's lymphomas;Greil;Oncology,1998

4. A predictive model for aggressive non-Hodgkin's lymphoma;The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

5. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age;Armitage;J Am Geriatr Soc,1984

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia;Journal of Clinical Medicine;2023-08-29

2. Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR;Current Medical Research and Opinion;2022-09-01

3. Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer;The Prostate;2022-06-29

4. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy;Supportive Care in Cancer;2022-04-28

5. Evaluation of awareness about importance of high fever in leukemia and lymphoma patients receiving chemotherapy among healthcare professionals working in pharmacies other than hospital pharmacies: A survey from a Central Anatolian city;Journal of Oncology Pharmacy Practice;2022-01-17